NCT07809178Active, not recruiting
China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm
Treatment Strategies for Tumor in Sellar Region With Unruptured Intracranial Aneurysms in the Chinese Population
Source: ClinicalTrials.gov · Last updated 21 Oct 2026
Brief summary (registry, in English)
The goal of this observational study is to learn about the treatment strategies for tumor in sellar region with unruptured intracranial aneurysms in the Chinese population. The main question it aims to answer is: For patients with tumor in sellar region combined with unruptured intracranial aneurysms, which condition should be treated first?
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 608 (estimated)
- First submitted
- 17 Aug 2026
- Start date
- 20 Oct 2026
- Primary completion date
- 1 Sept 2028
- Lead sponsor
- Cheng sen
- Diseases
- Neuroendocrine tumours
- NCT number
- NCT07809178
What you commit to
- Study type: Observational
- Planned participants: 608
- From 20 Oct 2026 to the primary completion date, 1 Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with previously treated intracranial aneurysm.
Other illness
- Any other condition that, in the investigator's judgment, makes the patient unsuitable for trial participation.
Other
- Patients with recurrent sella region tumors.
- Pregnant or breastfeeding women.
Who the study is looking for
- Preoperative enhanced head MRI showing a suspected diagnosis of a sella region lesion, and preoperative head CTA/DSA confirming an unruptured intracranial aneurysm.
- Patients with primary sella region tumor and unruptured intracranial aneurysms that have not previously accepted surgical treatment.
- Patients with tumor in sellar region requiring craniotomy or endoscopic transnasal surgery and/or an aneurysm requiring craniotomy, endovascular treatment, or observation only.
- The patients are in good general health, without severe underlying medical conditions, and capable of tolerating surgical treatment.
- Patients or their legal guardians have signed an informed consent form and voluntarily agreed to participate in the clinical trial.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Tiantan Hospital Affiliated to Capital Medical University Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.